Which choice best describes the purpose of most pharmacogenomic research?To evaluate whether genetic testing can reduce the cost of pharmaceuticalsTo evaluate how different racial and ethnic groups respond to certain drugs or classes of drugsTo evaluate the association between individual genotypes and the safety and efficacy of a particular drug or class of drugsTo evaluate how the genomes of infectious agents impact the efficacy of certain antibiotics
The correct answer and explanation is:
The correct answer is: To evaluate the association between individual genotypes and the safety and efficacy of a particular drug or class of drugs.
Explanation
Pharmacogenomics is the study of how an individual’s genetic makeup influences their response to drugs. The primary purpose of this field is to understand the relationship between genetic variations and the safety, efficacy, or metabolism of medications. By identifying genetic factors that affect drug response, pharmacogenomics aims to enable personalized medicine—tailoring drug therapies to individual genetic profiles for optimal results.
- Safety: Some genetic variants can make individuals more susceptible to adverse drug reactions. For example, variations in the CYP2C19 gene can affect the metabolism of clopidogrel, a blood-thinning medication. Individuals with certain genetic variants might not metabolize the drug effectively, leading to reduced efficacy and increased risk of adverse events.
- Efficacy: Genetic differences can influence how well a drug works for a person. For instance, variations in the HER2 gene affect the efficacy of trastuzumab in treating certain types of breast cancer. Patients whose tumors overexpress the HER2 protein benefit from the drug, while others do not.
- Drug Metabolism: Genes like CYP450 family members (e.g., CYP2D6) play a crucial role in how drugs are processed. Understanding these genetic variations can prevent underdosing or overdosing.
Pharmacogenomic research also supports drug development by identifying genetic markers associated with therapeutic outcomes, thus streamlining clinical trials and improving success rates. It has the potential to reduce healthcare costs by minimizing adverse drug reactions, avoiding ineffective treatments, and improving overall patient outcomes.
In contrast to the other options, pharmacogenomics is not primarily focused on racial or ethnic group responses, reducing pharmaceutical costs, or studying infectious agents’ genomes. Instead, its central goal is to understand the individual genetic basis of drug response.